Department of defense alzheimer's disease blood-testing initiative (DOD-adbi): a study to accelerate blood-based diagnosis of alzheimer's in veterans

The Defense Health Agency awarded a $2.8 million Project Grant to The Sheba Fund For Health Services And Research (R.a.) under the Military Medical Research and Development program (CFDA 12.420). The grant will support the Department of Defense Alzheimer's Disease Blood-Testing Initiative (DOD-ADBI) from September 2022 to September 2026.

The DOD-ADBI study aims to accelerate the development of blood-based diagnostics for Alzheimer's disease among veterans. Specifically, the grantee will conduct research to investigate medical solutions for early and non-invasive Alzheimer's diagnosis using blood tests. By supporting this innovative research, the grant seeks to transform healthcare for service members and the public through new diagnostic tools that could help identify Alzheimer's disease earlier and more easily. The work will be performed in Israel by The Sheba Fund, with the goal of investigating blood-based diagnostic approaches for Alzheimer's disease.